Skip to main content
Premium Trial:

Request an Annual Quote

WTSI Signs on to iRODS Consortium

Premium

The Wellcome Trust Sanger Institute has joined the Integrated Rule-Oriented Data System (iRODS) Consortium, the entity that supports a highly-configurable open source infrastructure used globally for data management, sharing, and integration.

The iRODS Consortium was founded about a year ago by the Renaissance Computing Institute (RENCI) at the University of North Carolina-Chapel Hill and the Max Planck Society. Its purpose is to bring together universities, research organizations, businesses, and government agencies to guide the continued development of the iRODS data management platform, which was created by the Data Intensive Cyber Environments group at UNC-Chapel Hill and the University of California at San Diego; to obtain funding to support development efforts; and to broaden the community of users.

"We are delighted to join the iRODS Consortium," Guy Coates, team leader of WTSI's informatics systems group, said in a statement. "We need efficient management systems to ensure that our large-scale datasets are of value … [we] need to make sure we can produce, manage and use genome information as efficiently as possible."

Brand Fortner, the director of the iRODS Consortium and a senior researcher at RENCI, said in his comments that WTSI "will be an extremely valuable member of the consortium."

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.